Metronidazole Market Report 2026

Metronidazole Market Overview

• Metronidazole market size has reached to $0.61 billion in 2025 • Expected to grow to $0.8 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: Increasing Incidence Of Bacterial Infections Propels The Market Growth • Market Trend: Advancements In Metronidazole Formulations To Improve Patient Compliance • Asia-Pacific was the largest region in 2025.

What Is Covered Under Metronidazole Market?

Metronidazole is an antibiotic and antiprotozoal drug used to treat bacterial and parasitic infections. It works by penetrating microbial cells, where bacterial and protozoal enzymes reduce it, generating reactive nitrogen species. These reactive compounds damage DNA, causing strand breakage and inhibiting nucleic acid synthesis, ultimately disrupting replication and transcription, leading to cell death. The main types of metronidazole formulations are tablets, capsules, intravenous (IV) solutions, topical creams or ointments, and others. Metronidazole tablets are oral medications used to treat bacterial and parasitic infections, offering sustained effects with easy, effective outpatient treatment. They are applicable in various applications such as bacterial infections, parasitic infections, gynecological infections, surgical prophylaxis, and others, and are distributed through several distribution channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others. It is used by various end-users, such as hospitals, clinics, homecare, and others.

What Is The Metronidazole Market Growth Forecast?

The metronidazole market size is expected to see strong growth in the next few years. It will grow to $0.8 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rising global infection burden, increasing hospital admissions, sustained demand for affordable antibiotics, expansion of outpatient antimicrobial therapy, growth in emerging healthcare markets. Major trends in the forecast period include widespread use in anaerobic bacterial infections, growing demand for broad-spectrum antimicrobials, expansion of topical and oral formulations, increased use in gynecological and gastrointestinal infections, rising preference for cost-effective generic antibiotics.

Global Metronidazole Market Segmentation

1) By Formulation Type: Tablets, Capsules, Intravenous (IV) Solutions, Topical Creams Or Ointments, Other Formulation Types 2) By Application: Bacterial Infections, Parasitic Infections, Gynecological Infections, Surgical Prophylaxis, Other Applications 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels 4) By End-User: Hospitals, Clinics, Homecare, Other End Users Subsegments: 1) By Tablets: Immediate Release Tablets, Extended Release Tablets 2) By Capsules: Immediate Release Capsules, Extended Release Capsules 3) By Intravenous (IV) Solutions: Single-dose IV Solutions, Multi-dose IV Solutions 4) By Topical Creams Or Ointments: Topical Creams, Topical Ointments 5) By Other Formulation Types: Oral Suspension, Vaginal Gels Or Suppositories

What Is The Driver Of The Metronidazole Market?

The increasing incidence of bacterial infections is expected to propel the growth of the metronidazole market going forward. Bacterial infections are diseases caused by the growth and multiplication of harmful bacteria in the body. The increasing incidence of bacterial infections is driven by factors such as antibiotic resistance, environmental changes, and the rise in immunocompromised populations. Metronidazole targets bacterial DNA, causing damage that halts reproduction and spread. This makes it effective against anaerobic bacteria and certain protozoal infections, inhibiting bacterial growth and treating the infection. For instance, in November 2025, according to the UK Health Security Agency, a UK-based government agency, cases of antibiotic-resistant bacteraemia, a life-threatening infection in which bacteria enter the bloodstream have risen by 9.3% since 2023, increasing from 18,740 cases in 2023 to 20,484 in 2024. Therefore, the increasing incidence of bacterial infections will drive the growth of the metronidazole industry.

Key Players In The Global Metronidazole Market

Major companies operating in the metronidazole market are Pfizer Inc., Merck & Co. Inc., Abbott Laboratories, Fresenius Kabi AG, Baxter International Inc., Sandoz Group AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Lupin Pharmaceuticals Inc., Zydus Lifesciences, YiChang HEC ChangJiang Pharmaceutical Co. Ltd., Aarti Drugs Ltd., Unichem Laboratories, Cosette Pharmaceuticals Inc., Saptalis Pharmaceuticals LLC, Huanggang Saikang Pharmaceutical Co. Ltd., Kesin Pharma, Hubei Hongyuan Pharmaceutical Technology Co. Ltd., Huanggang Yinhe Aarti Pharmaceutical Co. Ltd., Higgs Healthcare

Global Metronidazole Market Trends and Insights

Major companies operating in the metronidazole market are focusing on developing advanced products, such as ready-to-use oral liquids, to enhance patient compliance, especially for those who have difficulty swallowing tablets or require easier administration for the treatment of infections. Ready-to-use oral liquids are pre-formulated liquid medications that do not require further preparation or mixing before administration, providing convenience for patients. For instance, in November 2023, Kesin Pharma Corporation, a US-based specialty pharmaceutical company, announced that the Food and Drug Administration (FDA) approved LIKMEZ (metronidazole) oral suspension, 500 mg/5 mL. It is a novel formulation of a common antibiotic drug designed to improve patient adherence and approved for treating trichomoniasis and anaerobic bacterial infections in adults, as well as amebiasis in adults and children. LIKMEZ is presented as a strawberry peppermint-flavored suspension in a 200 mL bottle, with a 24-month shelf life that does not require refrigeration.

What Are Latest Mergers And Acquisitions In The Metronidazole Market?

In April 2023, Marksans Pharma, an India-based pharmaceutical company, acquired a manufacturing facility from Teva Pharmaceutical Industries for an undisclosed amount. This acquisition will enable Marksans to potentially double its existing production capacity from 8 billion units per year. Teva Pharmaceutical Industries is an India-based pharmaceutical company that manufactures metronidazole tablets.

Regional Insights

Asia-Pacific was the largest region in the metronidazole market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Metronidazole Market?

The metronidazole market consists of sales of oral suspension, suppositories, and gel. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Metronidazole Market Report 2026?

The metronidazole market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the metronidazole industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.